CT confirms relationship between HIV-related inflammation and the increase of CAD among men infected with HIV.
Noncontrast CT scans show a link between higher inflammatory biomarkers and increased prevalence of coronary artery disease (CAD) in men infected with HIV, according to a study published in the Journal of the American Heart Association.
Researchers from California, Maryland, Vermont, and Pennsylvania investigated associations of inflammatory markers with subclinical coronary artery disease in men with HIV. A total of 923 participants of the Multicenter AIDS Cohort Study were part of the study; 575 were HIV-positive and 348 were HIV-negative. All underwent noncontrast CT scans for coronary artery calcification; 692 also underwent coronary CT angiography. The researchers were looking for presence and extent of coronary artery calcification, plus CT angiography analysis of presence, composition, and extent of coronary plaques and severity of coronary stenosis
The results showed that men who were HIV-positive had significantly higher levels of interleukinâ6 (ILâ6), intercellular adhesion moleculeâ1, Câreactive protein, and solubleâtumor necrosis factorâα receptor (sTNFαR) I and II, and a higher prevalence of noncalcified plaque (63% versus 54%) on CT angiography. As well, among the men who were HIV-positive, for every SD increase in logâinterleukinâ6 and log intercellular adhesion moleculeâ1, there was a 30% and 60% increase, respectively, in the prevalence of coronary stenosis 50 or higher. Similarly, sTNFαR I and II in HIV-positive participants were associated with an increase in prevalence of coronary stenosis 70% or higher). Higher levels of interleukinâ6, sTNFαR I, and sTNFαR II were also associated with greater coronary artery calcification score in HIV-positive men.[[{"type":"media","view_mode":"media_crop","fid":"51229","attributes":{"alt":"Hossein Bahrami, MD, PhD","class":"media-image media-image-right","id":"media_crop_5280059448608","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"6311","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":"Hossein Bahrami, MD, PhD","typeof":"foaf:Image"}}]]
“Although this study does not definitely prove the causal relationship between these markers and heart disease, it is suggestive of a possible role that persistent inflammation (even in HIV infected patients that are under appropriate treatments) may play in increasing the risk of heart disease in these patients,” lead author Hossein Bahrami, MD, PhD, assistant professor of cardiovascular medicine at the Keck School of Medicine of the University of Southern California (USC), said in a release.
"Inflammation has only recently been studied as a possible reason for chronic heart disease," Bahrami said. "Confirming the relationship between HIV-related inflammation and the marked increase of CAD among men infected with HIV allows us to move forward in our attempts to better manage the health of these patients according to their specific medical needs."
New Study Assesses Benefits of High-Resolution Photon-Counting for Computed Tomography Angiography
October 10th 2024Researchers found that ultra-high resolution photon-counting significantly enhanced visualization of small vessels and facilitated improved reduction of blooming artifacts for head and neck computed tomography angiography (CTA) scans.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.